Surgery After Downstaging of Unresectable Hepatic Tumors With Intra-Arterial Chemotherapy

Abstract Background: This retrospective study was performed to assess the outcome among patients who underwent hepatic resection or tumor ablation after hepatic artery infusion (HAI) therapy downstaged previously unresectable hepatocellular carcinoma (HCC) or liver metastases from colorectal cancer ... Ausführliche Beschreibung

1. Person: Meric, Funda
Weitere Personen: Patt, Yehuda Z.; Curley, Steve A.; Chase, Judy; Roh, Mark S.; Vauthey, J. Nicolas; Ellis, Lee M.
Quelle: in Annals of surgical oncology : the official journal of the Society of Surgical Oncology Vol. 7 (2000), p. 490-495
Weitere Artikel
Format: Online-Artikel
Genre: Hepatic artery infusion, Chemotherapy, Colorectal cancer, Metastases, Hepatocellular cancer
Sprache: English
Veröffentlicht: 2000
Beschreibung: Online-Ressource
Online Zugang: Online
Volltext
Tags: Hinzufügen
Keine Tags. Fügen Sie den ersten Tag hinzu!
Anmerkung: Copyright: Copyright 2000 The Society of Surgical Oncology, Inc.
LEADER 03507nma a2200493 c 4500
001 NLEJ207543690
003 DE-601
005 20110129054502.0
007 cr uuu---uuuuu
008 070528s2000 000 0 eng d
016 7 |a 20740219  |2 DE-600 
040 |b ger  |c GBVCP 
041 0 |a eng 
084 |a soj  |2 natliz 
245 0 0 |a Surgery After Downstaging of Unresectable Hepatic Tumors With Intra-Arterial Chemotherapy  |h Elektronische Ressource 
300 |a Online-Ressource 
500 |a Copyright: Copyright 2000 The Society of Surgical Oncology, Inc. 
520 |a Abstract Background: This retrospective study was performed to assess the outcome among patients who underwent hepatic resection or tumor ablation after hepatic artery infusion (HAI) therapy downstaged previously unresectable hepatocellular carcinoma (HCC) or liver metastases from colorectal cancer (CRC). Methods: Between 1983 and 1998, 25 patients with HCC and 383 patients with hepatic CRC metastases were treated with HAI therapy for unresectable liver disease. We retrospectively reviewed the records of 26 (6%) of these patients who underwent subsequent surgical exploration for tumor resection or ablation. Results: At a median of 9 months (range 7–12 months) after HAI treatment, four patients (16%) with HCC underwent exploratory surgery; two underwent resection with negative margins, and the other two were given radiofrequency ablation (RFA) because of underlying cirrhosis. At a median postoperative follow-up of 16 months (range 6–48 months), all four patients were alive with no evidence of disease. At a median of 14.5 months (range 8–24 months) after HAI therapy, 22 patients with hepatic CRC metastases underwent exploratory surgery; 10 underwent resection, 6 underwent resection and RFA or cryotherapy, and 2 underwent RFA only. At a median follow-up of 17 months, 15 (83%) of the 18 patients with CRC who had received surgical treatment had developed recurrent disease; the other 3 died of other causes (1 of postoperative complications) within 7 months of the surgery. One patient in whom disease recurred underwent a second resection and was disease-free at 1 year follow-up. Conclusions: Hepatic resection or ablation after tumor downstaging with HAI therapy is a viable option for patients with unresectable HCC. However, given the high rate of recurrence of metastases from CRC, hepatic resection or ablation after downstaging with HAI should be used with caution. 
533 |a Online edition  |f Springer Online Journal Archives 1860-2002 ; 041039-1 
655 7 |a Hepatic artery infusion  |2 gnd 
655 7 |a Chemotherapy  |2 gnd 
655 7 |a Colorectal cancer  |2 gnd 
655 7 |a Metastases  |2 gnd 
655 7 |a Hepatocellular cancer  |2 gnd 
689 0 0 |a Hepatic artery infusion 
689 0 1 |a Chemotherapy 
689 0 2 |a Colorectal cancer 
689 0 3 |a Metastases 
689 0 4 |a Hepatocellular cancer 
689 0 |5 DE-601 
700 1 |a Meric, Funda 
700 1 |a Patt, Yehuda Z. 
700 1 |a Curley, Steve A. 
700 1 |a Chase, Judy 
700 1 |a Roh, Mark S. 
700 1 |a Vauthey, J. Nicolas 
700 1 |a Ellis, Lee M. 
773 0 8 |i in  |t Annals of surgical oncology : the official journal of the Society of Surgical Oncology  |g Vol. 7 (2000), p. 490-495  |q 7<490-495  |w (DE-601)NLEJ188993851  |x 1534-4681 
856 4 0 |u http://dx.doi.org/10.1007/s10434-000-0490-2 
901 |a OLC 
912 |a ZDB-1-SOJ 
912 |a GBV_NL_ARTICLE 
951 |a AR 
952 |d 7  |j 2000  |c 7  |h 490-495  |g 6 

Ähnliche Einträge

Keine ähnlichen Titel gefunden

Privacy Notice Ask a Librarian New Acquisitions